Precision Medicine
Recent Developments in Immune Profiling for Early Immuno-Oncology Trials
immune profiling; immuno-oncology; clinical trials; AI in immunotherapy; multi-omic strategies; tumor microenvironment; spatial proteomics; biomarker discovery; personalized medicine
Illuminating the CKD Patient Journey: Clinicogenomic Data Reshapes Research & Drug Discovery
chronic kidney disease; CKD; clinicogenomics; drug discovery; cell therapy; gene therapy; clinical trials; personalized medicine
Antares Therapeutics Launches with $177M to Tackle ‘Undruggable’ Targets After Scorpion Spinout
Antares Therapeutics; Scorpion Therapeutics; biotech spinoff; $177M Series A; undruggable targets; oncology; precision medicine; Eli Lilly acquisition; preclinical pipeline
Precision Medicine’s Next Frontier: Unlocking the Power of Biospecimens
precision medicine; biospecimens; multi-omics; drug development; biobanking; personalized medicine; biomarkers; spatial transcriptomics; cancer genomics
Recent Developments in NLP and Generative AI for Life Sciences and Precision Medicine (2025)
NLP; Generative AI; life sciences; precision medicine; healthcare; large language models; multimodal AI; quality management; drug discovery; pharmacovigilance
ASCO25 Primer: Navigating Cancer R&D Amid Regulatory Uncertainty
ASCO25; cancer research; oncology; regulatory uncertainty; immunotherapy; precision medicine; diagnostics; expert perspectives; policy changes
Navigating the Biotech Winter: Strategies for Survival and Growth Amid Ongoing Industry Downturn
biotech downturn, layoff trends, funding challenges, strategic adaptation, innovation, mergers & acquisitions, workforce planning, precision medicine, artificial intelligence, regulatory landscape, survival strategies, growth opportunities
Alzheon Investigates Subgroup Data Following Phase 3 Trial of ALZ-801 in Alzheimer’s Disease
Alzheimer’s disease , ALZ-801 , Valiltramiprosate , APOE4 genotype , Mild cognitive impairment (MCI) , Amyloid-targeting therapy , Phase 3 trial results , Cognitive decline , Subgroup analysis , Precision medicine
Galatea Bio’s $25M Funding Boost for Global Biobank and AI-Driven Genomic Research
Galatea Bio, global biobank, AI-enabled genomic analysis, precision medicine, non-European ancestry, genetic diversity
Oncology Market in 2025: Innovation, Growth, and Patient-Centric Care
Cancer immunotherapy, Targeted therapies , Precision medicine, AI in oncology, Combination treatments, Biosimilars, Clinical trial design, Personalized cancer care